Gilead recalls vials of its Remdesivir covid drug in U.S. due to glass contamination

American biopharmaceutical company Gilead Sciences Inc. has issued a nationwide recall of two lots of its coronavirus treatment drug Remdesivir due to the "presence of glass particulates," the company said Friday.

Read at Washington Post